标题
Effect of an Inhibitor on the ACE2-Receptor-Binding Domain of SARS-CoV-2
作者
关键词
-
出版物
Journal of Chemical Information and Modeling
Volume -, Issue -, Pages -
出版商
American Chemical Society (ACS)
发表日期
2022-02-04
DOI
10.1021/acs.jcim.1c01283
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ACE-2-Derived Biomimetic Peptides for the Inhibition of Spike Protein of SARS-CoV-2
- (2021) Saroj Kumar Panda et al. JOURNAL OF PROTEOME RESEARCH
- The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose
- (2021) Zain Chagla ANNALS OF INTERNAL MEDICINE
- Potential inhibitors of angiotensin converting enzyme 2 receptor of COVID-19 by Corchorus olitorius Linn using docking, molecular dynamics, conceptual DFT investigation and pharmacophore mapping
- (2021) Fouzia Mesli et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2
- (2021) Billy J. Williams-Noonan et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19
- (2021) Suresh Gangadevi et al. Journal of Physical Chemistry Letters
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
- (2021) Merryn Voysey et al. LANCET
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021
- (2021) Sara E. Oliver et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Accelerating COVID-19 Research Using Molecular Dynamics Simulation
- (2021) Aditya K. Padhi et al. JOURNAL OF PHYSICAL CHEMISTRY B
- A glycan gate controls opening of the SARS-CoV-2 spike protein
- (2021) Terra Sztain et al. Nature Chemistry
- Adverse events following ChAdOx1 nCoV-19 Vaccine (COVISHIELD) amongst health care workers: A prospective observational study
- (2021) Deep Kamal et al. Medical Journal Armed Forces India
- The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China
- (2020) David S. Hui et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
- (2020) Xiaolong Tian et al. Emerging Microbes & Infections
- Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2
- (2020) Yanxiao Han et al. ACS Nano
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
- (2020) Wanbo Tai et al. Cellular & Molecular Immunology
- Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
- (2020) Xiangyu Chen et al. Cellular & Molecular Immunology
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- (2020) James M. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
- (2020) Hasan K. Siddiqi et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Is the Rigidity of SARS-CoV-2 Spike Receptor-Binding Motif the Hallmark for Its Enhanced Infectivity? Insights from All-Atoms Simulations
- (2020) Angelo Spinello et al. Journal of Physical Chemistry Letters
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
- (2020) Zhenming Jin et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
- (2020) Yadi Zhou et al. Cell Discovery
- Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients
- (2020) Xiaoli Wang et al. CLINICAL INFECTIOUS DISEASES
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- (2020) Georgia Ragia et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The Development of Coronavirus 3C-Like Protease (3CLpro) Inhibitors from 2010 to 2020
- (2020) Yuzhi Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
- (2020) Xiangyang Chi et al. SCIENCE
- Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
- (2020) Alina Baum et al. SCIENCE
- In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
- (2020) Franck Touret et al. Scientific Reports
- Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach
- (2020) Shweta Choudhary et al. Frontiers in Immunology
- Substrate-Dependent Mobile Loop Conformational Changes in Alkanesulfonate Monooxygenase from Accelerated Molecular Dynamics
- (2020) Abhishek Thakur et al. BIOCHEMISTRY
- Alkamides and Piperamides as Potential Antivirals against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Juan Manuel Gutierrez-Villagomez et al. Journal of Physical Chemistry Letters
- In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
- (2020) Irene Maffucci et al. JOURNAL OF PROTEOME RESEARCH
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
- (2020) Longxing Cao et al. SCIENCE
- Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
- (2020) Mohammad M. Ghahremanpour et al. ACS Medicinal Chemistry Letters
- An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors
- (2020) Alfonso Trezza et al. Scientific Reports
- Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
- (2020) Lorenzo Casalino et al. ACS Central Science
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Identification of potential non-nucleoside MraY inhibitors for tuberculosis chemotherapy using structure-based virtual screening
- (2020) Pankaj Pandey et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Theoretical Design of Functionalized Gold Nanoparticles as Antiviral Agents against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Aliyeh Mehranfar et al. Journal of Physical Chemistry Letters
- Oxford–AstraZeneca COVID-19 vaccine efficacy
- (2020) Maria Deloria Knoll et al. LANCET
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2020) Yanjun Zhang et al. LANCET INFECTIOUS DISEASES
- Phe71 in Type III Trypanosomal Protein Arginine Methyltransferase 7 (TbPRMT7) Restricts the Enzyme to Monomethylation
- (2018) Tamar B. Cáceres et al. BIOCHEMISTRY
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- The Drug Repurposing Hub: a next-generation drug library and information resource
- (2017) Steven M Corsello et al. NATURE MEDICINE
- Pre-fusion structure of a human coronavirus spike protein
- (2016) Robert N. Kirchdoerfer et al. NATURE
- A comprehensive map of molecular drug targets
- (2016) Rita Santos et al. NATURE REVIEWS DRUG DISCOVERY
- Systematic Parameterization of Monovalent Ions Employing the Nonbonded Model
- (2015) Pengfei Li et al. Journal of Chemical Theory and Computation
- ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
- (2015) James A. Maier et al. Journal of Chemical Theory and Computation
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
- (2014) John Mair-Jenkins et al. JOURNAL OF INFECTIOUS DISEASES
- Rational Design of Particle Mesh Ewald Compatible Lennard-Jones Parameters for +2 Metal Cations in Explicit Solvent
- (2013) Pengfei Li et al. Journal of Chemical Theory and Computation
- Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
- (2013) G. Madhavi Sastry et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
- (2013) R. J. de Groot et al. JOURNAL OF VIROLOGY
- Design of Angiotensin-converting Enzyme 2 (ACE2) Inhibitors by Virtual Lead Optimization and Screening
- (2012) Juan E. Torres et al. JOURNAL OF THE CHINESE CHEMICAL SOCIETY
- H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations
- (2012) R. Anandakrishnan et al. NUCLEIC ACIDS RESEARCH
- Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays
- (2011) Kim Brint Pedersen et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice
- (2009) John J. Byrnes et al. INFLAMMATION RESEARCH
- Development of Potent and Selective Phosphinic Peptide Inhibitors of Angiotensin-Converting Enzyme 2
- (2008) Andreas Mores et al. JOURNAL OF MEDICINAL CHEMISTRY
- Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
- (2008) Roy M. Gulick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thiol-based angiotensin-converting enzyme 2 inhibitors: P1 modifications for the exploration of the S1 subsite
- (2007) David N. Deaton et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now